These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Design and application of hybrid cyclic-linear peptide-doxorubicin conjugates as a strategy to overcome doxorubicin resistance and toxicity. Mozaffari S; Salehi D; Mahdipoor P; Beuttler R; Tiwari R; Aliabadi HM; Parang K Eur J Med Chem; 2021 Dec; 226():113836. PubMed ID: 34537446 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiproliferative activities of doxorubicin thiol conjugates and doxorubicin-SS-cyclic peptide. Darwish S; Sadeghiani N; Fong S; Mozaffari S; Hamidi P; Withana T; Yang S; Tiwari RK; Parang K Eur J Med Chem; 2019 Jan; 161():594-606. PubMed ID: 30396106 [TBL] [Abstract][Full Text] [Related]
4. Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs. Nasrolahi Shirazi A; Tiwari R; Chhikara BS; Mandal D; Parang K Mol Pharm; 2013 Feb; 10(2):488-99. PubMed ID: 23301519 [TBL] [Abstract][Full Text] [Related]
5. Amphiphilic Cell-Penetrating Peptides Containing Arginine and Hydrophobic Residues as Protein Delivery Agents. Moreno J; Zoghebi K; Salehi D; Kim L; Shoushtari SK; Tiwari RK; Parang K Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986567 [TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and Evaluation of Homochiral Peptides Containing Arginine and Histidine as Molecular Transporters. El-Sayed NS; Miyake T; Shirazi AN; Park SE; Clark J; Buchholz S; Parang K; Tiwari R Molecules; 2018 Jun; 23(7):. PubMed ID: 29966296 [TBL] [Abstract][Full Text] [Related]
7. Amphiphilic Cell-Penetrating Peptides Containing Natural and Unnatural Amino Acids as Drug Delivery Agents. Salehi D; Mozaffari S; Zoghebi K; Lohan S; Mandal D; Tiwari RK; Parang K Cells; 2022 Mar; 11(7):. PubMed ID: 35406720 [TBL] [Abstract][Full Text] [Related]
8. Comparative Molecular Transporter Properties of Cyclic Peptides Containing Tryptophan and Arginine Residues Formed through Disulfide Cyclization. Mohammed EHM; Mandal D; Mozaffari S; Abdel-Hamied Zahran M; Mostafa Osman A; Kumar Tiwari R; Parang K Molecules; 2020 Jun; 25(11):. PubMed ID: 32498339 [TBL] [Abstract][Full Text] [Related]
9. Transferrin Receptor Targeted Cellular Delivery of Doxorubicin Via a Reduction-Responsive Peptide-Drug Conjugate. Li S; Zhao H; Mao X; Fan Y; Liang X; Wang R; Xiao L; Wang J; Liu Q; Zhao G Pharm Res; 2019 Oct; 36(12):168. PubMed ID: 31654226 [TBL] [Abstract][Full Text] [Related]
10. Cyclic Peptide Containing Hydrophobic and Positively Charged Residues as a Drug Delivery System for Curcumin. Shirazi AN; El-Sayed NS; Tiwari RK; Tavakoli K; Parang K Curr Drug Deliv; 2016; 13(3):409-17. PubMed ID: 26511089 [TBL] [Abstract][Full Text] [Related]
11. A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells. Song Q; Chuan X; Chen B; He B; Zhang H; Dai W; Wang X; Zhang Q Drug Deliv; 2016 Jun; 23(5):1734-46. PubMed ID: 25853477 [TBL] [Abstract][Full Text] [Related]
12. Peptide-Based Hydrogels and Nanogels for Delivery of Doxorubicin. Gallo E; Diaferia C; Rosa E; Smaldone G; Morelli G; Accardo A Int J Nanomedicine; 2021; 16():1617-1630. PubMed ID: 33688182 [TBL] [Abstract][Full Text] [Related]
13. Efficient Intracellular Delivery of Cell-Impermeable Cargo Molecules by Peptides Containing Tryptophan and Histidine. Shirazi AN; Mozaffari S; Sherpa RT; Tiwari R; Parang K Molecules; 2018 Jun; 23(7):. PubMed ID: 29949881 [TBL] [Abstract][Full Text] [Related]
14. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging. Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307 [TBL] [Abstract][Full Text] [Related]
15. A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance. Bidwell GL; Davis AN; Fokt I; Priebe W; Raucher D Invest New Drugs; 2007 Aug; 25(4):313-26. PubMed ID: 17483874 [TBL] [Abstract][Full Text] [Related]
16. Hybrid Cyclic-Linear Cell-Penetrating Peptides Containing Alternative Positively Charged and Hydrophobic Residues as Molecular Transporters. Khayyatnejad Shoushtari S; Zoghebi K; Sajid MI; Tiwari RK; Parang K Mol Pharm; 2021 Oct; 18(10):3909-3919. PubMed ID: 34491768 [TBL] [Abstract][Full Text] [Related]
17. Cyclic peptide-capped gold nanoparticles as drug delivery systems. Nasrolahi Shirazi A; Mandal D; Tiwari RK; Guo L; Lu W; Parang K Mol Pharm; 2013 Feb; 10(2):500-11. PubMed ID: 22998473 [TBL] [Abstract][Full Text] [Related]
18. A doxorubicin-CNGRC-peptide conjugate with prodrug properties. van Hensbergen Y; Broxterman HJ; Elderkamp YW; Lankelma J; Beers JC; Heijn M; Boven E; Hoekman K; Pinedo HM Biochem Pharmacol; 2002 Mar; 63(5):897-908. PubMed ID: 11911842 [TBL] [Abstract][Full Text] [Related]
19. Poly (l-γ-glutamylglutamine) Polymer Enhances Doxorubicin Accumulation in Multidrug Resistant Breast Cancer Cells. Peng T; Liu K; Gao L; Gao L; Chen J; Wang J; Liu Y; Wang Y; Yan Z; Yu L Molecules; 2016 Jun; 21(6):. PubMed ID: 27271578 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and Antiproliferative Activities of Conjugates of Paclitaxel and Camptothecin with a Cyclic Cell-Penetrating Peptide. El-Sayed NS; Shirazi AN; Sajid MI; Park SE; Parang K; Tiwari RK Molecules; 2019 Apr; 24(7):. PubMed ID: 30978971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]